Skip to main content
GoodMoatv1.3
Sign in
ELUT logo

ELUT

Compare

Elutia Inc - Class A

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Aziyo Biologics Inc - Class A

Did you know?

Price sits at 26% of its 52-week range.

Current Price

$1.01

-0.98%
Profile
Valuation (TTM)
Market Cap$43.13M
P/E0.81
EV—
P/B1.56
Shares Out42.70M
P/Sales2.28
Revenue$18.89M
EV/EBITDA0.31

Elutia Inc - Class A (ELUT) Financial Statements

ELUT Financial Data

EBITDA$57.70M
Revenue (TTM)$18.89M
Gross Profit (TTM)$9.28M
Gross Margin—
Operating Margin-218.91%
ROE192.90%
ROA85.61%
Debt/Equity0.40
Current Ratio2.22
FCF$-46.69M
FCF Yield-108.25%
Piotroski F-Score—
Rev/Share (TTM)$0.44
50-Day MA$1.11
200-Day MA$1.14
Shares Outstanding0.04B

ELUT Computed Insights

FCF—
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

ELUT Financial Statements & Data

Elutia Inc - Class A (ELUT) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Elutia Inc - Class A's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $18.89M. Gross profit (TTM) is $9.28M. EBITDA is $57.70M. Earnings per share (EPS) is $0.87. The P/E ratio is 0.81. Market capitalization is $43.13M.

Weighted average cost of capital (WACC) is 10.00%.

GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Elutia Inc - Class A's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.